β-Hydroxybutyrate and Citrate Synthase as Potential Diagnostic Biomarkers in Aging-Related Atrial Fibrillation

Jia-Kang He1, Xiao-Xiao Jiang1, Shi-Yu Dai1

  • 1Department of Cardiology, First Affiliated Hospital of Dalian Medical University, No.193, Lianhe Road, Xigang District, Dalian, 116011, China.

Insights

Aging increases atrial fibrillation (AF) risk. Reduced beta-hydroxybutyrate (β-OHB) and citrate synthase (CS) activity in elderly AF patients suggest mitochondrial dysfunction and atrial remodeling, potentially serving as biomarkers for age-related AF.

Area of Science:

  • Biochemistry
  • Cardiology
  • Gerontology

Background:

  • The incidence of atrial fibrillation (AF) rises with age, but the underlying mechanisms and effective biomarkers for elderly patients are not fully understood.
  • Aging is a significant risk factor for AF, necessitating research into age-specific pathological pathways.
  • Identifying reliable biomarkers is crucial for managing AF in the aging population.

Purpose of the Study:

  • To investigate the role of beta-hydroxybutyrate (β-OHB) and citrate synthase (CS) activity in age-related atrial fibrillation (AF).
  • To explore the association between metabolic factors, mitochondrial function, and atrial remodeling in elderly AF patients.
  • To identify potential diagnostic biomarkers for AF in elderly individuals.

Main Methods:

  • Analysis of plasma samples from 100 elderly AF patients, 100 young NAF patients, and 100 elderly NAF patients.
  • Assessment of citrate synthase (CS) activity in plasma samples.
  • Examination of left atrial tissues from AF and NAF patients undergoing valve replacement for mitochondrial dysfunction and structural remodeling.

Main Results:

  • Elderly AF patients exhibited significantly lower levels of β-OHB and reduced CS activity compared to elderly NAF patients.
  • A protective association was found between higher β-OHB levels and CS activity and the occurrence of AF in the elderly.
  • Atrial tissues from elderly AF patients showed evidence of mitochondrial dysfunction, structural remodeling, and low-voltage areas.

Conclusions:

  • Dysregulation of β-OHB and CS activity may contribute to aging-related AF by impacting mitochondrial function and atrial remodeling.
  • β-OHB and CS activity show potential as diagnostic biomarkers for age-related atrial fibrillation.
  • Targeting mitochondrial dysfunction and metabolic pathways could offer new therapeutic strategies for elderly AF patients.